Stay updated with breaking news from Nasdaq Rvph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $20.00 target price on the stock. Reviva Pharmaceuticals Stock Performance Shares of NASDAQ:RVPH opened at $3.78 on Monday. The firm has a fifty day moving […]
CUPERTINO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage...
HC Wainwright reiterated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $20.00 target price on the stock. Separately, Roth Mkm restated a buy rating and set a $12.00 target price on shares of Reviva Pharmaceuticals […]
HC Wainwright restated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $20.00 price target on the stock. RVPH has been the topic of several other reports. Roth Mkm reissued a buy rating and issued a $12.00 price target […]
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Equities researchers at Zacks Small Cap lowered their FY2023 EPS estimates for Reviva Pharmaceuticals in a research note issued to investors on Monday, November 20th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will post earnings per share of ($1.43) for the year, […]